BioNTech SE (BNTX)
100.60
+1.85
(+1.87%)
USD |
NASDAQ |
May 31, 16:00
100.51
-0.09
(-0.09%)
After-Hours: 20:00
BioNTech Enterprise Value: 7.581B for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 31, 2024 | 7.581B |
May 30, 2024 | 7.135B |
May 29, 2024 | 5.804B |
May 28, 2024 | 6.014B |
May 24, 2024 | 6.701B |
May 23, 2024 | 7.195B |
May 22, 2024 | 7.990B |
May 21, 2024 | 5.525B |
May 20, 2024 | 5.621B |
May 17, 2024 | 5.173B |
May 16, 2024 | 5.744B |
May 15, 2024 | 5.556B |
May 14, 2024 | 5.576B |
May 13, 2024 | 5.682B |
May 10, 2024 | 5.429B |
May 09, 2024 | 5.523B |
May 08, 2024 | 5.057B |
May 07, 2024 | 5.238B |
May 06, 2024 | 5.833B |
May 03, 2024 | 5.682B |
May 02, 2024 | 5.566B |
May 01, 2024 | 5.014B |
April 30, 2024 | 4.742B |
April 29, 2024 | 4.532B |
April 26, 2024 | 4.354B |
Date | Value |
---|---|
April 25, 2024 | 4.233B |
April 24, 2024 | 4.566B |
April 23, 2024 | 4.662B |
April 22, 2024 | 4.547B |
April 19, 2024 | 4.257B |
April 18, 2024 | 4.103B |
April 17, 2024 | 4.159B |
April 16, 2024 | 4.144B |
April 15, 2024 | 4.518B |
April 12, 2024 | 4.178B |
April 11, 2024 | 4.306B |
April 10, 2024 | 4.701B |
April 09, 2024 | 5.038B |
April 08, 2024 | 4.860B |
April 05, 2024 | 4.856B |
April 04, 2024 | 4.718B |
April 03, 2024 | 4.918B |
April 02, 2024 | 5.096B |
April 01, 2024 | 5.474B |
March 31, 2024 | 5.267B |
March 28, 2024 | 3.879B |
March 27, 2024 | 4.050B |
March 26, 2024 | 3.748B |
March 25, 2024 | 4.057B |
March 22, 2024 | 3.779B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
2.452B
Minimum
Oct 14 2019
107.68B
Maximum
Aug 09 2021
24.31B
Average
19.57B
Median
Enterprise Value Benchmarks
Pfizer Inc | 219.46B |
Moderna Inc | 46.11B |
GSK PLC | 107.78B |
NuCana PLC | -8.064M |
Autolus Therapeutics PLC | 356.16M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -342.26M |
Revenue (Quarterly) | 203.77M |
Total Expenses (Quarterly) | 754.69M |
EPS Diluted (Quarterly) | -1.423 |
Gross Profit Margin (Quarterly) | 68.50% |
Profit Margin (Quarterly) | -168.0% |
Earnings Yield | 0.48% |
Normalized Earnings Yield | 0.6856 |